Caribou Biosciences, Inc. Revenue 2019–2025
Caribou Biosciences, Inc. annual/quarterly revenue history and growth rate from 2019 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Caribou Biosciences, Inc. revenue for the quarter ending March 31, 2026 was 2.4 M, a 1.87% increase year-over-year.
- Caribou Biosciences, Inc. revenue for the twelve months ending March 31, 2026 was 9.6 M, a 69.55% decrease year-over-year.
- Caribou Biosciences, Inc. annual revenue for 2025 was 11.2 M, a 11.66% increase from 2024.
- Caribou Biosciences, Inc. annual revenue for 2024 was 10.0 M, a 71.01% decrease from 2023.
- Caribou Biosciences, Inc. annual revenue for 2023 was 34.5 M, a 148.91% increase from 2022.
- Caribou Biosciences, Inc. annual revenue for 2022 was 13.9 M.
Caribou Biosciences, Inc. (CRBU) — Frequently Asked Questions
Caribou Biosciences, Inc. (CRBU) is a publicly traded US company. It has a market capitalization of $167M. In fiscal 2025 it reported revenue of $11M and net income of -$148M. Explore CRBU's stock price, financial statements, earnings history, margins and key ratios below.
What is Caribou Biosciences, Inc.'s market cap?
Caribou Biosciences, Inc. (CRBU) has a market capitalization of $167M.
What is the CRBU stock price?
CRBU trades at $1.79 (-2.72% on the day).
How much revenue does Caribou Biosciences, Inc. make?
Caribou Biosciences, Inc. reported revenue of $11M in fiscal 2025.
Is CRBU profitable?
In fiscal 2025, Caribou Biosciences, Inc. reported net income of -$148M.